Companies: 10,795·Total market cap: $144.5T
Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc.

STOKNASDAQHealthcare● Active
$29.00
$-1.01(-3.37%)
Market Cap$1.8B
P/E Ratio
52W High$40.22
52W Low$10.635
Overview

Stoke Therapeutics, Inc. (STOK) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

stok · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 15 Wall Street analysts in the past 3 months

SellBuy

Buy

15 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
12
Hold
3
Sell
0
Strong Sell
0
Total: 15 · Buy rate: 80.0%

12-Month Price Target

High

$60.00

Consensus

$43.86

+51.2% upside

Low

$35.00

Median: $40 · Last Close: $29.00

The Stoke Therapeutics, Inc. (STOK) analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month STOK price target is $43.86, representing +51.2% upside from the current price of $29.00.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $44 (51.2%)

Consensus Target

$43.86

51.2% upside

High Target

$60

106.9%

Low Target

$35

20.7%

Current Price

$29.00

as of today

Based on analyst price targets, the STOK stock price prediction for the next 12 months ranges from $35 to $60. The consensus STOK price forecast of $43.86 implies 51.2% upside from the current price of $29.00.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$28.332.32%

1-day model range: $28.19–$28.46. Peak: $28.46 (-2.32%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$35+20.9%
2028$39+34.8%
2029$42+43.4%
2030$43+48.4%
2031+51.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%7%86%
1Buy
1Neutral
12Sell
RSI (14)49.9Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · STOK · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$29.45SELL
MA 10$30.27SELL
MA 20$30.47SELL
MA 50$32.59SELL
MA 100$32.72SELL
MA 200$30.33SELL
Current $STOK · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$29.65SELL
EMA 10$29.98SELL
EMA 20$30.64SELL
EMA 50$31.86SELL
EMA 100$31.76SELL
EMA 200$28.90BUY
Current $STOK · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
BTIG2026-05-11
Maintains
BuyBuy
Canaccord Genuity2026-03-20
Maintains
BuyBuy
BTIG2026-03-19
Maintains
BuyBuy
Chardan Capital2026-03-18
Maintains
BuyBuy
Wedbush2026-03-18
Maintains
OutperformOutperform
Needham2026-03-17
Maintains
BuyBuy
Wedbush2026-03-17
Maintains
OutperformOutperform
Wedbush2026-01-12
Maintains
OutperformOutperform
Canaccord Genuity2026-01-05
Maintains
BuyBuy
Chardan Capital2026-01-05
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Stoke Therapeutics, Inc. (STOK) stock. Of the recent 93 rating actions, 4 were upgrades and 1 were downgrades. 15 analysts currently cover STOK.

Analyst Recommendation Trends

Buy ratings211
Hold ratings00
Sell ratings00

STOK analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$26M

↓ 79.2% YoY

Revenue Next Year

$46M

↑ 76.2% YoY

EPS This Year

$-3.22

EPS Next Year

$-3.12

↓ 3.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast STOK EPS of $-3.22 for the current fiscal year, based on estimates from 8 analysts. The STOK revenue forecast is $26M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The STOK stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus STOK price target is $43.86 (+51.2% upside), with an analyst consensus of Buy.

The STOK short-term stock prediction for tomorrow is $28.33 (-2.32%). The STOK stock price prediction for 2027 estimates an average of $35. The STOK stock prediction for 2030 projects a range of $41–$45.

Stoke Therapeutics, Inc. trades on NASDAQ under the ticker STOK. The STOK stock outlook for 2027 is broadly positive, supported by a Buy consensus among 80% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

STOK forecast · 8 questions

According to 15 Wall Street analysts, the average 12-month STOK price target is $43.86, with a high forecast of $60.00 and a low of $35.00. The median price target is shown in the chart above when available. This implies +51.2% potential upside from the current price of $29.00.

STOK price targetWhat is STOK price targetSTOK analyst price targetSTOK 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.